Private Equity
The exit, which was made in light of Romanian regulatory changes on the horizon, came as a ‘disappointment’ to the renewable energy-focused private equity firm, which had looked forward to building the largest wind farm development in Europe.
2 min read · 05 January 2013
The mid-market turnaround specialist has backed the buyout of Crown Paints from Dutch conglomerate Akzo Nobel in a deal fully underwritten by Endless’ second £164m fund. The deal value, though not disclosed, was lower than the reported £70m.
2 min read · 05 January 2013
The number of buyouts in Continental Europe in the first half of 2008 was down 19 percent compared to the same period last year, while the average deal size has dropped from €113 million to €70 million.
1 min read · 05 January 2013
Investors from outside Europe, including private equity firms, could be affected by an amendment to Germany’s Foreign Trade Act approved today.
2 min read · 05 January 2013
Foxtons, the UK estate agency owned by global buyout group BC Partners, is having a tough time amid the housing market slowdown. Investment bankers from NM Rothschild are reportedly being asked to advise on a refinancing of the company’s £250m debt package.
1 min read · 05 January 2013
The turnaround investor now holds 75 percent of Wagon following a €47m special rights offering. London Stock Exchange-listed Wagon designs vehicle structures for brands including Peugeot, Renault, Daimler and Volkswagen.
1 min read · 05 January 2013
The EVCA has appointed 11 new mid-market members to its board of directors. Named as its board chairman in June, 3i's Jonathan Russell has said the EVCA must help the public understand that most market participants are not mega-firms involved in headline-grabbing deals, but focus on fuelling SME growth.
2 min read · 05 January 2013
The global public markets are proving a fruitful hunting ground for private equity buyers. Swedish group Gunnebo is the latest company to move into private hands.
1 min read · 05 January 2013
European venture deals have hit a nine-year low. But Germany and cleantech remain bright spots, writes Amanda Janis.
2 min read · 04 January 2013
Paris-based specialty pharmaceutical company SpePharm will use €10m to fund the acquisition of a Proctor & Gamble product.
1 min read · 04 January 2013
